GAY, Francesca Maria
GAY, Francesca Maria
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease
2016-01-01 Zamagni E.; Nanni C.; Gay F.; Pezzi A.; Patriarca F.; Bello M.; Rambaldi I.; Tacchetti P.; Hillengass J.; Gamberi B.; Pantani L.; Magarotto V.; Versari A.; Offidani M.; Zannetti B.; Carobolante F.; Balma M.; Musto P.; Rensi M.; Mancuso K.; Dimitrakopoulou-Strauss A.; Chauvie S.; Rocchi S.; Fard N.; Marzocchi G.; Storto G.; Ghedini P.; Palumbo A.; Fanti S.; Cavo M.
2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde
2021-01-01 Musto, Pellegrino; Engelhardt, Monika; Caers, Jo; Bolli, Niccolo'; Kaiser, Martin; Van de Donk, Niels; Terpos, Evangelos; Broijl, Annemiek; De Larrea, Carlos Fernández; Gay, Francesca; Goldschmidt, Hartmut; Hajek, Roman; Vangsted, Annette Juul; Zamagni, Elena; Zweegman, Sonja; Cavo, Michele; Dimopoulos, Meletios; Einsele, Hermann; Ludwig, Heinz; Barosi, Giovanni; Boccadoro, Mario; Mateos, Maria-Victoria; Sonneveld, Pieter; Miguel, Jesus San
A Case-Matched Analysis Comparing Lenalidomide After Autologous or After Allogeneic Stem Cell Transplantation Demonstrates a Survival Advantage in Allografted Myeloma Patients
2012-01-01 Vittorio Montefusco; Francesco Spina; Elena Zamagni; Benedetto Bruno; Francesca Gay; Francesca Patriarca; Giorgia Saporiti; Monica Galli; Claudia Crippa; Lucia Farina; Anna Maria Cafro; Angelo Michele Carella; Paolo Corradini
A Multicenter, Open Label Study of Oral Lenalidomide and Prednisone (RP) Followed by Oral Lenalidomide Melphalan and Prednisone (MPR) and Oral Lenalidomide Maintenance In Newly Diagnosed Elderly Multiple Myeloma Patients
2010-01-01 Palumbo A; Falco P; Benevolo G; Rossi D; Carella AM; Guglielmelli T; Rocci A; De Paoli L; Grasso M; Mosca Siez ML; Piro E; Caltagirone S; Gay F; Cavallo F; Gaidano G; Boccadoro M
A new combination for advanced multiple myeloma.
2011-01-01 Palumbo A; Gay F.
A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma
2024-01-01 Sonneveld, Pieter; Dimopoulos, Meletios A.; Boccadoro, Mario; Quach, Hang; Ho, P. Joy; Beksac, Meral; Hulin, Cyrille; Antonioli, Elisabetta; Leleu, Xavier; Mangiacavalli, Silvia; Perrot, Aurore; Cavo, Michele; Belotti, Angelo; Broijl, Annemiek; Gay, Francesca; Mina, Roberto; van de Donk, Niels W.C.J.; Katodritou, Eirini; Schjesvold, Fredrik; Balari, Anna Sureda; Rosiñol, Laura; Delforge, Michel; Roeloffzen, Wilfried; Silzle, Tobias; Vangsted, Annette; Einsele, Hermann; Spencer, Andrew; Hajek, Roman; Jurczyszyn, Artur; Lonergan, Sarah; Ahmadi, Tahamtan; Liu, Yanfang; Wang, Jianping; Vieyra, Diego; van Brummelen, Emilie M.J.; Vanquickelberghe, Veronique; Sitthi-Amorn, Anna; de Boer, Carla J.; Carson, Robin; Rodriguez-Otero, Paula; Bladé, Joan; Moreau, Philippe
A Post-Market Economic Evaluation of Bortezomib, Lenalidomide and Dexamethasone Versus Pre-funding Standard of Care for Newly Diagnosed Multiple Myeloma Using Registry Data
2026-01-01 Irving, Adam; Petrie, Dennis; Harris, Anthony; Fanning, Laura; Wood, Erica M; Moore, Elizabeth; Wellard, Cameron; Waters, Neil; Augustson, Bradley; Cook, Gordon; Gay, Francesca; McCaughan, Georgia; Mollee, Peter; Spencer, Andrew; McQuilten, Zoe K
A Prospective, Randomized, Phase III Study of Melphalan 200 mg/m2 (Mel200) Versus Melphalan 100 mg/m2 (Mel100) in Newly Diagnosed Myeloma Patients.
2007-01-01 Palumbo A; Bringhen S; Petrucci MT; Falcone A; Liberati AM; Lauta VM; Grasso M; Montanaro M; Pisani F; Caravita T; Cangialosi C; Pregno P; Nozza A; Calabrese E; Gay F; Cavallo F; Omedè P; Musto P; Foà R; Boccadoro M
A rational approach to functional high-risk myeloma
2023-01-01 Gay, Francesca; Bertuglia, Giuseppe; Mina, Roberto
A Simple Score, Based On Geriatric Assessment, Improves Prediction of Survival, and Risk Of Serious Adverse Events In Elderly Newly Diagnosed Multiple Myeloma Patients
2013-01-01 Larocca, A; Bringhen, S; Evangelista, A; Offidani, M; Ballanti, S; Zaccaria, A; Pescosta, N; Montefusco, V; De Rosa, L; Carella, Am; Baldini, L; Aglietta, M; Vincelli, Id; Marasca, R; Pezzati, S; Tosi, P; Cocito, F; Grasso, M; Fioritoni, G; Pavone, V; Musto, P; Grammatico, S; Omede, P; Gay, F; Ciccone, G; Boccadoro, M; Palumbo, A
ACHIEVEMENT OF COMPLETE REMISSION IS A STRONG PROGNOSTIC FACTOR IN 895 ELDERLY MYELOMA PATIENTS TREATED WITH MELPHALAN-PREDNISONE BASED-REGIMENS: RESULTS OF 3 MULTICENTER ITALIAN TRIALS
2010-01-01 F Gay; A Larocca; MT Petrucci; P Musto; AM Liberati; V Callea; R Ria; T Caravita; C Cangialosi; M Grasso; M Offidani; P Pregno; F Patriarca; M Galli; M Cavo; L Catalano; C Nozzoli; T Guglielmelli; R Zambello; F Pisani; V Montefusco; F Rossini; V De Stefano; B Lupo; F Di Raimondo; G Gaidano; M Boccadoro; A Palumbo
Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells
2024-01-01 D'Agostino, Mattia; Rota-Scalabrini, Delia; Belotti, Angelo; Bertamini, Luca; Arigoni, Maddalena; De Sabbata, Giovanni; Pietrantuono, Giuseppe; Pascarella, Anna; Tosi, Patrizia; Pisani, Francesco; Pescosta, Norbert; Ruggeri, Marina; Rogers, Jennifer; Olivero, Martina; Garzia, Mariagrazia; Galieni, Piero; Annibali, Ombretta; Monaco, Federico; Liberati, Anna Marina; Palmieri, Salvatore; Stefanoni, Paola; Zamagni, Elena; Bruno, Benedetto; Calogero, Raffaele Adolfo; Boccadoro, Mario; Musto, Pellegrino; Gay, Francesca
An IL-1β-driven neutrophil-stromal cell axis fosters a BAFF-rich protumor microenvironment in individuals with multiple myeloma
2024-01-01 de Jong, Madelon M E; Fokkema, Cathelijne; Papazian, Natalie; Czeti, Ágnes; Appelman, Marjolein K; Vermeulen, Michael; van Heusden, Teddie; Hoogenboezem, Remco M; van Beek, Gregory; Tahri, Sabrin; Sanders, Mathijs A; van de Woestijne, Pieter C; Gay, Francesca; Moreau, Philippe; Büttner-Herold, Maike; Bruns, Heiko; van Duin, Mark; Broijl, Annemiek; Sonneveld, Pieter; Cupedo, Tom
Anti-CD38 monoclonal antibodies in multiple myeloma: another cook in the kitchen?
2020-01-01 D'Agostino M.; Mina R.; Gay F.
Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates
2008-01-01 Montefusco V; Gay F; Spina F; Miceli R; Maniezzo M; Teresa Ambrosini M; Farina L; Piva S; Palumbo A; Boccadoro M; Corradini P.
Antibody-drug conjugates: when chemotherapy meets immuno-oncology
2021-01-01 Mina R.; Gay F.
Are we ready for an MRD-driven approach in multiple myeloma?
2025-01-01 Gay, Francesca; Mina, Roberto
ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Multiple Myeloma
2022-01-01 Dhakal, Binod; Shah, Nina; Kansagra, Ankit; Kumar, Ambuj; Lonial, Sagar; Garfall, Alfred; Cowan, Andrew; Poudyal, Bishesh Sharma; Costello, Caitlin; Gay, Francesca; Cook, Gordon; Quach, Hang; Einsele, Herman; Schriber, Jeff; Hou, Jian; Costa, Luciano; Aljurf, Mahmoud; Chaudhry, Maria; Beksac, Meral; Prince, Miles; Mohty, Mohamad; Janakiram, Murali; Callander, Natalie; Biran, Noa; Malhotra, Pankaj; Otero, Paula Rodriguez; Moreau, Philippe; Abonour, Rafat; Iftikhar, Raheel; Silberman, Rebecca; Mailankody, Sham; Gregory, Tara; Lin, Yi; Carpenter, Paul; Hamadani, Mehdi; Usmani, Saad; Kumar, Shaji
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
2020-01-01 Cavo M.; Gay F.; Beksac M.; Pantani L.; Petrucci M.T.; Dimopoulos M.A.; Dozza L.; van der Holt B.; Zweegman S.; Oliva S.; van der Velden V.H.J.; Zamagni E.; Palumbo G.A.; Patriarca F.; Montefusco V.; Galli M.; Maisnar V.; Gamberi B.; Hansson M.; Belotti A.; Pour L.; Ypma P.; Grasso M.; Croockewit A.; Ballanti S.; Offidani M.; Vincelli I.D.; Zambello R.; Liberati A.M.; Andersen N.F.; Broijl A.; Troia R.; Pascarella A.; Benevolo G.; Levin M.-D.; Bos G.; Ludwig H.; Aquino S.; Morelli A.M.; Wu K.L.; Boersma R.; Hajek R.; Durian M.; von dem Borne P.A.; Caravita di Toritto T.; Zander T.; Specchia G.; Waage A.; Gimsing P.; Mellqvist U.-H.; van Marwijk Kooy M.; Minnema M.; Mandigers C.; Cafro A.M.; Palmas A.; Carvalho S.; Spencer A.; Boccadoro M.; Sonneveld P.
Autologous transplant for myeloma: When the old meets the new
2017-01-01 Gay, Francesca*; Genuardi, Mariella; Boccadoro, Mario
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease | 2016 | Zamagni E.; Nanni C.; Gay F.; Pezzi A.; Patriarca F.; Bello M.; Rambaldi I.; Tacchetti P.; Hillengass J.; Gamberi B.; Pantani L.; Magarotto V.; Versari A.; Offidani M.; Zannetti B.; Carobolante F.; Balma M.; Musto P.; Rensi M.; Mancuso K.; Dimitrakopoulou-Strauss A.; Chauvie S.; Rocchi S.; Fard N.; Marzocchi G.; Storto G.; Ghedini P.; Palumbo A.; Fanti S.; Cavo M. | |
| 2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde | 2021 | Musto, Pellegrino; Engelhardt, Monika; Caers, Jo; Bolli, Niccolo'; Kaiser, Martin; Van de Donk, Niels; Terpos, Evangelos; Broijl, Annemiek; De Larrea, Carlos Fernández; Gay, Francesca; Goldschmidt, Hartmut; Hajek, Roman; Vangsted, Annette Juul; Zamagni, Elena; Zweegman, Sonja; Cavo, Michele; Dimopoulos, Meletios; Einsele, Hermann; Ludwig, Heinz; Barosi, Giovanni; Boccadoro, Mario; Mateos, Maria-Victoria; Sonneveld, Pieter; Miguel, Jesus San | |
| A Case-Matched Analysis Comparing Lenalidomide After Autologous or After Allogeneic Stem Cell Transplantation Demonstrates a Survival Advantage in Allografted Myeloma Patients | 2012 | Vittorio Montefusco; Francesco Spina; Elena Zamagni; Benedetto Bruno; Francesca Gay; Francesca Patriarca; Giorgia Saporiti; Monica Galli; Claudia Crippa; Lucia Farina; Anna Maria Cafro; Angelo Michele Carella; Paolo Corradini | |
| A Multicenter, Open Label Study of Oral Lenalidomide and Prednisone (RP) Followed by Oral Lenalidomide Melphalan and Prednisone (MPR) and Oral Lenalidomide Maintenance In Newly Diagnosed Elderly Multiple Myeloma Patients | 2010 | Palumbo A; Falco P; Benevolo G; Rossi D; Carella AM; Guglielmelli T; Rocci A; De Paoli L; Grasso M; Mosca Siez ML; Piro E; Caltagirone S; Gay F; Cavallo F; Gaidano G; Boccadoro M | |
| A new combination for advanced multiple myeloma. | 2011 | Palumbo A; Gay F. | |
| A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma | 2024 | Sonneveld, Pieter; Dimopoulos, Meletios A.; Boccadoro, Mario; Quach, Hang; Ho, P. Joy; Beksac, Meral; Hulin, Cyrille; Antonioli, Elisabetta; Leleu, Xavier; Mangiacavalli, Silvia; Perrot, Aurore; Cavo, Michele; Belotti, Angelo; Broijl, Annemiek; Gay, Francesca; Mina, Roberto; van de Donk, Niels W.C.J.; Katodritou, Eirini; Schjesvold, Fredrik; Balari, Anna Sureda; Rosiñol, Laura; Delforge, Michel; Roeloffzen, Wilfried; Silzle, Tobias; Vangsted, Annette; Einsele, Hermann; Spencer, Andrew; Hajek, Roman; Jurczyszyn, Artur; Lonergan, Sarah; Ahmadi, Tahamtan; Liu, Yanfang; Wang, Jianping; Vieyra, Diego; van Brummelen, Emilie M.J.; Vanquickelberghe, Veronique; Sitthi-Amorn, Anna; de Boer, Carla J.; Carson, Robin; Rodriguez-Otero, Paula; Bladé, Joan; Moreau, Philippe | |
| A Post-Market Economic Evaluation of Bortezomib, Lenalidomide and Dexamethasone Versus Pre-funding Standard of Care for Newly Diagnosed Multiple Myeloma Using Registry Data | 2026 | Irving, Adam; Petrie, Dennis; Harris, Anthony; Fanning, Laura; Wood, Erica M; Moore, Elizabeth; Wellard, Cameron; Waters, Neil; Augustson, Bradley; Cook, Gordon; Gay, Francesca; McCaughan, Georgia; Mollee, Peter; Spencer, Andrew; McQuilten, Zoe K | |
| A Prospective, Randomized, Phase III Study of Melphalan 200 mg/m2 (Mel200) Versus Melphalan 100 mg/m2 (Mel100) in Newly Diagnosed Myeloma Patients. | 2007 | Palumbo A; Bringhen S; Petrucci MT; Falcone A; Liberati AM; Lauta VM; Grasso M; Montanaro M; Pisani F; Caravita T; Cangialosi C; Pregno P; Nozza A; Calabrese E; Gay F; Cavallo F; Omedè P; Musto P; Foà R; Boccadoro M | |
| A rational approach to functional high-risk myeloma | 2023 | Gay, Francesca; Bertuglia, Giuseppe; Mina, Roberto | |
| A Simple Score, Based On Geriatric Assessment, Improves Prediction of Survival, and Risk Of Serious Adverse Events In Elderly Newly Diagnosed Multiple Myeloma Patients | 2013 | Larocca, A; Bringhen, S; Evangelista, A; Offidani, M; Ballanti, S; Zaccaria, A; Pescosta, N; Montefusco, V; De Rosa, L; Carella, Am; Baldini, L; Aglietta, M; Vincelli, Id; Marasca, R; Pezzati, S; Tosi, P; Cocito, F; Grasso, M; Fioritoni, G; Pavone, V; Musto, P; Grammatico, S; Omede, P; Gay, F; Ciccone, G; Boccadoro, M; Palumbo, A | |
| ACHIEVEMENT OF COMPLETE REMISSION IS A STRONG PROGNOSTIC FACTOR IN 895 ELDERLY MYELOMA PATIENTS TREATED WITH MELPHALAN-PREDNISONE BASED-REGIMENS: RESULTS OF 3 MULTICENTER ITALIAN TRIALS | 2010 | F Gay; A Larocca; MT Petrucci; P Musto; AM Liberati; V Callea; R Ria; T Caravita; C Cangialosi; M Grasso; M Offidani; P Pregno; F Patriarca; M Galli; M Cavo; L Catalano; C Nozzoli; T Guglielmelli; R Zambello; F Pisani; V Montefusco; F Rossini; V De Stefano; B Lupo; F Di Raimondo; G Gaidano; M Boccadoro; A Palumbo | |
| Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells | 2024 | D'Agostino, Mattia; Rota-Scalabrini, Delia; Belotti, Angelo; Bertamini, Luca; Arigoni, Maddalena; De Sabbata, Giovanni; Pietrantuono, Giuseppe; Pascarella, Anna; Tosi, Patrizia; Pisani, Francesco; Pescosta, Norbert; Ruggeri, Marina; Rogers, Jennifer; Olivero, Martina; Garzia, Mariagrazia; Galieni, Piero; Annibali, Ombretta; Monaco, Federico; Liberati, Anna Marina; Palmieri, Salvatore; Stefanoni, Paola; Zamagni, Elena; Bruno, Benedetto; Calogero, Raffaele Adolfo; Boccadoro, Mario; Musto, Pellegrino; Gay, Francesca | |
| An IL-1β-driven neutrophil-stromal cell axis fosters a BAFF-rich protumor microenvironment in individuals with multiple myeloma | 2024 | de Jong, Madelon M E; Fokkema, Cathelijne; Papazian, Natalie; Czeti, Ágnes; Appelman, Marjolein K; Vermeulen, Michael; van Heusden, Teddie; Hoogenboezem, Remco M; van Beek, Gregory; Tahri, Sabrin; Sanders, Mathijs A; van de Woestijne, Pieter C; Gay, Francesca; Moreau, Philippe; Büttner-Herold, Maike; Bruns, Heiko; van Duin, Mark; Broijl, Annemiek; Sonneveld, Pieter; Cupedo, Tom | |
| Anti-CD38 monoclonal antibodies in multiple myeloma: another cook in the kitchen? | 2020 | D'Agostino M.; Mina R.; Gay F. | |
| Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates | 2008 | Montefusco V; Gay F; Spina F; Miceli R; Maniezzo M; Teresa Ambrosini M; Farina L; Piva S; Palumbo A; Boccadoro M; Corradini P. | |
| Antibody-drug conjugates: when chemotherapy meets immuno-oncology | 2021 | Mina R.; Gay F. | |
| Are we ready for an MRD-driven approach in multiple myeloma? | 2025 | Gay, Francesca; Mina, Roberto | |
| ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Multiple Myeloma | 2022 | Dhakal, Binod; Shah, Nina; Kansagra, Ankit; Kumar, Ambuj; Lonial, Sagar; Garfall, Alfred; Cowan, Andrew; Poudyal, Bishesh Sharma; Costello, Caitlin; Gay, Francesca; Cook, Gordon; Quach, Hang; Einsele, Herman; Schriber, Jeff; Hou, Jian; Costa, Luciano; Aljurf, Mahmoud; Chaudhry, Maria; Beksac, Meral; Prince, Miles; Mohty, Mohamad; Janakiram, Murali; Callander, Natalie; Biran, Noa; Malhotra, Pankaj; Otero, Paula Rodriguez; Moreau, Philippe; Abonour, Rafat; Iftikhar, Raheel; Silberman, Rebecca; Mailankody, Sham; Gregory, Tara; Lin, Yi; Carpenter, Paul; Hamadani, Mehdi; Usmani, Saad; Kumar, Shaji | |
| Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study | 2020 | Cavo M.; Gay F.; Beksac M.; Pantani L.; Petrucci M.T.; Dimopoulos M.A.; Dozza L.; van der Holt B.; Zweegman S.; Oliva S.; van der Velden V.H.J.; Zamagni E.; Palumbo G.A.; Patriarca F.; Montefusco V.; Galli M.; Maisnar V.; Gamberi B.; Hansson M.; Belotti A.; Pour L.; Ypma P.; Grasso M.; Croockewit A.; Ballanti S.; Offidani M.; Vincelli I.D.; Zambello R.; Liberati A.M.; Andersen N.F.; Broijl A.; Troia R.; Pascarella A.; Benevolo G.; Levin M.-D.; Bos G.; Ludwig H.; Aquino S.; Morelli A.M.; Wu K.L.; Boersma R.; Hajek R.; Durian M.; von dem Borne P.A.; Caravita di Toritto T.; Zander T.; Specchia G.; Waage A.; Gimsing P.; Mellqvist U.-H.; van Marwijk Kooy M.; Minnema M.; Mandigers C.; Cafro A.M.; Palmas A.; Carvalho S.; Spencer A.; Boccadoro M.; Sonneveld P. | |
| Autologous transplant for myeloma: When the old meets the new | 2017 | Gay, Francesca*; Genuardi, Mariella; Boccadoro, Mario |